Wegovy FlexTouch 2.4mg Solution for Injection in Pre-filled Pen (3ml)

145.150 KWD
Add to Wishlist

visamasteramerican expressnapsknetapple paygoogle paypaypal
DESCRIPTION

Wegovy FlexTouch 2.4 mg Solution for Injection in Pre-filled Pen (3 ml)

Wegovy FlexTouch 2.4 mg is a prescription medication used for chronic weight management in adults with obesity or who are overweight and have at least one weight-related health condition. It contains semaglutide, a GLP-1 (glucagon-like peptide-1) analogue, and is administered as a once-weekly subcutaneous injection.

Active Ingredient

  • Semaglutide 3.2 mg/mL

  • Each pre-filled pen contains 9.6 mg semaglutide in 3 mL solution, delivering four weekly doses of 2.4 mg each.

Indications

  • Used as an adjunct to a reduced-calorie diet and increased physical activity for weight management in adults with:

    • Body Mass Index (BMI) ≥30 kg/m² (obesity)

    • BMI ≥27 kg/m² (overweight) with at least one weight-related comorbidity (such as hypertension, type 2 diabetes, or dyslipidemia)

Dosage and Administration

  • Inject 2.4 mg subcutaneously once weekly, on the same day each week

  • Each FlexTouch pen contains four doses; use a new disposable needle for each injection

  • Injection sites: abdomen, thigh, or upper arm; rotate injection sites with each dose

  • The pen is compatible with NovoFine Plus, NovoFine, or NovoTwist disposable needles up to 8 mm in length

How It Works

  • Semaglutide mimics the action of GLP-1, a hormone that regulates appetite and food intake, helping to reduce hunger, improve satiety, and enhance control over eating behavior

Warnings and Precautions

  • Not recommended for individuals with a personal or family history of medullary thyroid carcinoma (MTC) or multiple endocrine neoplasia syndrome type 2 (MEN 2)

  • Use with caution in patients with a history of pancreatitis, diabetic retinopathy, or severe gastrointestinal disease

  • Inform your doctor if you are taking other diabetes medications, as dose adjustments may be necessary

Common Side Effects

  • Nausea, vomiting, diarrhea, constipation, abdominal pain, headache

  • Side effects are most common at the start of treatment and usually decrease over time

  • Seek medical attention for severe or persistent symptoms

Storage

  • Store in a refrigerator (2°C–8°C). Do not freeze

  • After first use, the pen can be kept at room temperature (below 30°C) for up to 6 weeks

  • Keep out of reach of children

Brand: Wegovy
Manufacturer: Novo Nordisk

Made in: Denmark